Parental medication use and risk of childhood acute lymphoblastic leukemia.

被引：0
|
作者：
Wen, WQ [1 ]
Shu, XO [1 ]
Potter, J [1 ]
Severson, RK [1 ]
Buckley, J [1 ]
Reaman, G [1 ]
Robison, L [1 ]
机构：
[1] Childrens Canc Grp, Arcadia, CA 91066 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 1999年 / 149卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
277
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [21] Potential application of differential glycosylation in childhood acute lymphoblastic leukemia.
    Chowdhury, Suchandra
    Mandal, Chandan
    Chandra, Sarmila
    BLOOD, 2006, 108 (11) : 196B - 196B
  • [22] 12p abnormalities in childhood acute lymphoblastic leukemia.
    Raimondi, SC
    Shurtleff, SA
    Downing, JR
    Mathew, S
    Pui, CH
    Rivera, GK
    Behm, FG
    BLOOD, 1995, 86 (10) : 690 - 690
  • [23] Analysis of deoxycytidine kinase mRNA in childhood acute lymphoblastic leukemia.
    Sauerbrey, A
    Stammler, G
    Volm, M
    Zintl, F
    BLOOD, 1997, 90 (10) : 1462 - 1462
  • [24] Expression of the Ikaros gene family in childhood acute lymphoblastic leukemia.
    Takanashi, M
    Yagi, T
    Morimoto, A
    Hibi, S
    Imashuku, S
    BLOOD, 2001, 98 (11) : 303A - 304A
  • [25] HLA VARIATION AND RISK OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA.
    Krasnow, Darif
    Skibola, Christine
    Vinson, Margaret
    Ladner, Martha
    Trachtenberg, Elizabeth
    HUMAN IMMUNOLOGY, 2011, 72 : S147 - S147
  • [26] Expression of receptor tyrosine kinases on lymphoblasts is related to the risk for relapse in childhood acute lymphoblastic leukemia.
    Schwinzer, B
    Schrappe, M
    Buhring, HJ
    Reiter, A
    Wittner, N
    Riehm, HJ
    Welte, K
    BLOOD, 1995, 86 (10) : 691 - 691
  • [27] Dynamics of minimal residual disease in relapsed childhood acute lymphoblastic leukemia.
    Beyermann, B
    Seeger, K
    Adams, HP
    Linderkamp, C
    Taube, T
    Schmid, H
    Hanel, C
    Henze, G
    BLOOD, 1998, 92 (10) : 393A - 393A
  • [28] Relevance of Wilms' tumor gene expression in childhood acute lymphoblastic leukemia.
    Gruhn, B
    Häfer, R
    Voigt, A
    Wittig, S
    Zintl, F
    BLOOD, 1999, 94 (10) : 492A - 492A
  • [29] Efficacy and safety of outpatient based therapy in childhood acute lymphoblastic leukemia.
    Zulfikar, Osman Bulent
    Koc, Basak
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Overexpression of AML1 predisposes to childhood acute lymphoblastic leukemia.
    Mikhail, FM
    Serry, KA
    Hatem, N
    Mourad, ZI
    Farawela, HM
    El Kaffash, DM
    Coignet, L
    Nucifora, G
    BLOOD, 2001, 98 (11) : 162B - 162B
12345